SEC Filing Update: #RAPP Rapport Therapeutics, Inc. : $47.42

Sector: Healthcare | YTD: 🔼+ 68.81% The SEC disclosed Today (14-AUG-2026) that Third Rock Ventures V, L.P. has DECREASED #RAPP Shares by -11.98% 🔴 * Previous Holdings: 7.14M Shares * Current Holdings: 6.28M Shares * Decrease -854.71K * Decreased (%)-11.98% * Ownership: 13.1% https://www.thinksabio.com/reports/isr/RAPP Institutional ownership in #RAPP has been steadily rising over the past 9 quarters in Shares: Q1 2024: 0.00 Q2 2024: 25.56M Q3 2024: 28.37M Q4 2024: 36.58M Q1 2025: 38.10M Q2 2025: 38.49M Q3 2025: 49.28M Q4 2025: 51.08M Q1 2026: 52.48M The quarterly average prices of #RAPP: Q3 2025: $17.85 Q4 2025: $27.63 Q1 2026: $28.14